Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients’ bone marrow

T cell based immunotherapies can be applicable to acute myeloid leukemia (AML). Therefore, the selection of optimal T cells, cell manufacturing, and therapeutic T cell engineering are essential for the development of effective adoptive T cell therapies for AML. Autologous tumor-infiltrating lymphocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Huynh, Kim, Do Hyun, Howard, Ashley, Moz, Hector, Wasnik, Samiksha, Baylink, David J., Chen, Chien-Shing, Reeves, Mark E, Mirshahidi, Saied, Xiao, Jeffrey, Francis, Olivia, Marcucci, Guido, Xu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603025/
https://www.ncbi.nlm.nih.gov/pubmed/34775232
http://dx.doi.org/10.1016/j.neo.2021.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603025/
https://www.ncbi.nlm.nih.gov/pubmed/34775232
http://dx.doi.org/10.1016/j.neo.2021.11.003

Ejemplares similares